Alpha1-Antichymotrypsin Level in Cerebrospinal Fluid is Closely Associated with Late Onset Alzheimer's Disease

Internal Medicine

Volumn 34, Issue 6, 1995, Pages 481-484

  Harigaya, Yasuo ^a   Shoji, Mikio ^a   Nakamura, Tamiko ^a   Matsubara, Etsuro ^a   Hirai, Shunsaku ^a   Hosoda, Kenji ^b  

^a GUNMA UNIVERSITY   (Japan)

^b TEIJIN LTD   (Japan)

Author keywords

diagnostic marker; enzyme immunoassay

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; FEMALE; HUMAN; MALE; METABOLISM; ONSET AGE; RADIOIMMUNOASSAY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T;

EID: 0029320845     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.34.481     Document Type: Article

References (17)

1. Rumble B, Retallack R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320: 1446, 1989.
2. Giaccone G, Tagliavini F, Linoli G, et al. Down's patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 97: 232, 1989.
3. Kelly VL, Cooper EH, Alexander C, Stone J. The assessment of antichymotrypsin in cancer monitoring. Biomedicine 28: 209, 1978.
4. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 52: 655, 1983.
5. Pasternack J, Abraham C, Van Dyke B, Potter H, Younkin S. Astrocytes in Alzheimer's disease gray matter express αl -antichymotrypsin mRNA. Am J Pathol 135: 827, 1989.
6. Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487, 1988.
7. Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Ishiguro K, Matsubara E. Alpha 1-antichymotrypsin is present in diffuse plaques. A comparative study of β-protein and α1-antichymotrypsin immunostaining in the Alzheimer brain. Am J Pathol 138: 247, 1991.
8. Roher AE, Palmer KC, Yurewicz EC, Ball MJ, Greenberg BD. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem 61: 1916, 1993.
9. Matsubara E, Hirai S, Amari M, et al. α1-Antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 28: 561, 1990.
10. Brugge K, Katzman R, Hill LR, Hansen LA, Saitoh T. Serological α1-antichymotrypsin in Down's syndrome and Alzheimer's disease. Ann Neurol 32: 193, 1992.
11. Furby A, Leys D, Delacourte A, Buee L, Soetart G, Petit H. Are alpha 1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease? J Neurol Neurosurg Psychiatry 54: 469, 1991.
12. Pirttila T, Mehta PD, Frey H, Wisniewski HM. α1-antichymo-trypsin and IL-1 b are not increased in CSF or serum in Alzheimer's disease? Neurobiol Aging 15: 313, 1994.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939, 1984.
14. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189, 1975.
15. Reisberg B, Ferris SH, Anand R, et al. Functional staging of dementia of the Alzheimer type. Ann NY Acad Sci 435: 481, 1984.
16. Shinohara Y, Yamamoto M, Ohsuga H, et al. Alpha 1 -anti-chymotrypsin and antitrypsin in CSF of patients with Alzheimer-type dementia. in: Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, Iqbal K, McLachlan DRC, Winblad B, Wisniewski M, Eds. John Wiley & Sons, Chichester, 1991, p541.
17. Clark RF, Goate AM. Molecular genetics of Alzheimer's disease. Arch Neurol 50: 1164, 1993.